Remdesvir-A Boon or a Bane..?

Abstract

Remdesivir is an antiviral drug, a novel nucleotide analog prodrug. It has been found to be an in-vitro potent inhibitor of RNA viruses including (severe acute respiratory syndrome coronavirus 2) SARS-CoV-2 but its in-vivo potency is still under active investigations. Coronavirus disease 2019 is an infectious disease caused by SARS-CoV-2. In the absence of a proven effective therapy, current management with remdesivir appears to have a favorable clinical safety profile, as reported on the basis of experience, including healthy volunteers and patients treated for acute Ebola virus infection.